Inventor · disambiguated record
Alexander O. Mujica
Also filed as: MUJICA ALEXANDER · MUJICA ALEXANDER O
31 granted patents·14 pending applications·96 citations·filing 2014–2024
96Inventor score
Files withREGENERON PHARMA45
Top patents by PatentIndex Score
45 records- 0198US10385359B2Targeted modification of rat genomeREGENERON PHARMA·Filed 2017·Granted Aug 20, 2019·29 cites·39 claims
- 0297US9795121B2Humanized C3 animalsREGENERON PHARMA·Filed 2015·Granted Oct 24, 2017·18 cites·23 claims
- 0393US10975390B2Targeted modification of rat genomeREGENERON PHARMA·Filed 2019·Granted Apr 13, 2021·4 cites·46 claims
- 0492US10070632B2Rodents having a humanized TMPRSS geneREGENERON PHARMA·Filed 2017·Granted Sep 11, 2018·5 cites·23 claims
- 0591US10306874B2Non-human animals having a humanized lymphocyte-activation gene 3REGENERON PHARMA·Filed 2016·Granted Jun 4, 2019·4 cites·10 claims
- 0691US10070631B2Rodents having a humanized TMPRSS geneREGENERON PHARMA·Filed 2017·Granted Sep 11, 2018·4 cites·22 claims
- 0789US10781453B2Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locusREGENERON PHARMA·Filed 2017·Granted Sep 22, 2020·6 cites·48 claims
- 0889US10390522B2Non-human animals having a humanized programmed cell death 1 geneREGENERON PHARMA·Filed 2015·Granted Aug 27, 2019·6 cites·15 claims
- 0988US9497945B2Humanized dipeptidyl peptidase IV (DPP4) animalsREGENERON PHARMA·Filed 2015·Granted Nov 22, 2016·5 cites·30 claims
- 1087US10492477B2Humanized C5 animalsREGENERON PHARMA·Filed 2017·Granted Dec 3, 2019·2 cites·26 claims
- 1187US2024397919A1Non-human animals having a humanized lymphocyte-activation gene 3REGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1286US12389889B2Mouse having a humanized cluster of differentiation 47 geneREGENERON PHARMA·Filed 2024·Granted Aug 19, 2025·0 cites·9 claims
- 1386US11178860B2Humanized C5 animalsREGENERON PHARMA·Filed 2019·Granted Nov 23, 2021·1 cites·20 claims
- 1486US9532555B2Humanized dipeptidyl peptidase IV (DPP4) animalsREGENERON PHARMA·Filed 2015·Granted Jan 3, 2017·4 cites·15 claims
- 1584US11589562B2Mouse model of DITRA disease and uses thereofREGENERON PHARMA·Filed 2019·Granted Feb 28, 2023·2 cites·27 claims
- 1684US10939673B2Method of using mouse having a humanized cluster of differentiation 47 geneREGENERON PHARMA·Filed 2018·Granted Mar 9, 2021·1 cites·7 claims
- 1783US11684050B2Non-human animals having a humanized programmed cell death 1 geneREGENERON PHARMA·Filed 2019·Granted Jun 27, 2023·1 cites·14 claims
- 1883US2024147971A1Rodents having a humanized tmprss geneREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1982US11102961B2Non-human animals having a humanized lymphocyte-activation gene 3REGENERON PHARMA·Filed 2019·Granted Aug 31, 2021·1 cites·18 claims
- 2082US2024298619A1Non-human animals having a humanized programmed cell death 1 geneREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2178US12037596B2Targeted modification of rat genomeREGENERON PHARMA·Filed 2021·Granted Jul 16, 2024·0 cites·5 claims
- 2277US12096754B2Non-human animals having a humanized lymphocyte-activation gene 3REGENERON PHARMA·Filed 2021·Granted Sep 24, 2024·0 cites·9 claims
- 2377US11910788B2Mouse having a humanized cluster of differentiation 47 geneREGENERON PHARMA·Filed 2021·Granted Feb 27, 2024·0 cites·12 claims
- 2477US2022132818A1Humanized c5 animalsREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 2576US11419318B2Genetically modified rat comprising a humanized TRKB locusREGENERON PHARMA·Filed 2018·Granted Aug 23, 2022·1 cites·9 claims
- 2676US10212923B2Humanized dipeptidyl-peptidase IV (DPP4) animalsREGENERON PHARMA·Filed 2016·Granted Feb 26, 2019·1 cites·24 claims
- 2775US12256720B2Humanized dipeptidyl-peptidase IV (DPP4) animalsREGENERON PHARMA·Filed 2021·Granted Mar 25, 2025·0 cites·5 claims
- 2875US10015953B2Non-human animals having a humanized cluster of differentiation 47 geneREGENERON PHARMA·Filed 2016·Granted Jul 10, 2018·1 cites·7 claims
- 2974US2023345919A1Non-human animals comprising a humanized asgr1 locusREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 3073US11013220B2Humanized dipeptidyl-peptidase IV (DPP4) animalsREGENERON PHARMA·Filed 2019·Granted May 25, 2021·0 cites·7 claims
- 3172US12471579B2Mouse model of DITRA disease and uses thereofREGENERON PHARMA·Filed 2023·Granted Nov 18, 2025·0 cites·6 claims
- 3272US11910787B2Rodents having a humanized TMPRSS geneREGENERON PHARMA·Filed 2020·Granted Feb 27, 2024·0 cites·21 claims
- 3371US12396444B2Mouse comprising a humanized TRKB locusREGENERON PHARMA·Filed 2022·Granted Aug 26, 2025·0 cites·14 claims
- 3471US10524458B2Humanized C3 animalsREGENERON PHARMA·Filed 2018·Granted Jan 7, 2020·0 cites·24 claims
- 3570US10863729B2Rodents having a humanized TMPRSS geneREGENERON PHARMA·Filed 2018·Granted Dec 15, 2020·0 cites·16 claims
- 3668US2014310828A1Targeted modification of rat genomeREGENERON PHARMA·Filed 2014·Application pending·0 cites
- 3763US2016060657A1Methods and compositions for the targeted modification of a genomeREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 3862US11696572B2Non-human animals comprising a humanized ASGR1 locusREGENERON PHARMA·Filed 2018·Granted Jul 11, 2023·0 cites·25 claims
- 3962US2014309487A1Targeted modification of rat genomeREGENERON PHARMA·Filed 2014·Application pending·0 cites
- 4060US2020370054A1Non-human animals having a hexanucleotide repeat expansion in a c9orf72 locusREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 4160US2018206462A1Non-human animals having a humanized programmed cell death 1 geneREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 4258US2025017183A1Non-human animals comprising a modified cacng1 locusREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 4357US2019062410A1Non-human animals having a mutant kynureninase geneREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 4456US2016345549A1Non-human animals having a humanized cluster of differentiation 47 geneREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 4552US2017247436A1Non-human animals having a mutant kynureninase geneREGENERON PHARMA·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →